Mark Poritz
Chief Tech/Sci/R&D Officer bei CO-DIAGNOSTICS, INC.
Aktive Positionen von Mark Poritz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CO-DIAGNOSTICS, INC. | Chief Tech/Sci/R&D Officer | 01.11.2022 | - |
Karriereverlauf von Mark Poritz
Ehemalige bekannte Positionen von Mark Poritz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Idaho Molecular, Inc.
 Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The private company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Chief Tech/Sci/R&D Officer | - | - |
Ausbildung von Mark Poritz
| University of California | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CO-DIAGNOSTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Idaho Molecular, Inc.
Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The private company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Health Technology |
- Börse
- Insiders
- Mark Poritz
- Erfahrung
